SMI Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
1,090
+2
+0.2% +$2.04K 0.21% 26
2026
Q1
$1.01M Buy
1,088
+1
+0.1% +$1.01K 0.17% 30
2025
Q4
$1.17M Buy
1,087
+2
+0.2% +$1.91K 0.2% 25
2025
Q3
$911K Buy
1,085
+2
+0.2% +$1.49K 0.17% 22
2025
Q2
$855K Buy
+1,083
New +$842K 0.17% 21
2025
Q1
Sell
-1,026
Closed -$818K 55
2024
Q4
$818K Sell
1,026
-1
-0.1% -$828 0.19% 32
2024
Q3
$911K Buy
1,027
+15
+1% +$13.5K 0.2% 37
2024
Q2
$943K Sell
1,012
-4,288
-81% -$3.43M 0.23% 39
2024
Q1
$4.01M Buy
+5,300
New +$3.77M 1.13% 26

Other funds holding LLY

SMI Advisory Services's LLY Position: Q2 2026 in Review

SMI Advisory Services increased its Eli Lilly (LLY) stake by 0.18% in Q2 2026, buying an estimated $2.04K and bringing the position to 1,090 shares worth $1.31M. The position accounts for 0.21% of the portfolio, ranked #26.

SMI Advisory Services first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.01M in Q1 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SMI Advisory Services held 1,090 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • SMI Advisory Services bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.21% of SMI Advisory Services's portfolio in Q2 2026, its #26 holding.
  • SMI Advisory Services first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • SMI Advisory Services's Eli Lilly position peaked at $4.01M in Q1 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SMI Advisory Services's 13F filing for Q2 2026, filed 9 Jul 2026.